Late effects of high-dose methotrexate treatment in childhood cancer survivors—a systematic review

BACKGROUND: High-dose methotrexate (HD-MTX) is used in the treatment of different childhood cancers, including leukemia, the most common cancer type and is commonly defined as an intravenous dose of at least 1 g/m(2) body surface area per application. A systematic review on late effects on different...

Descripción completa

Detalles Bibliográficos
Autores principales: Daetwyler, Eveline, Bargetzi, Mario, Otth, Maria, Scheinemann, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919635/
https://www.ncbi.nlm.nih.gov/pubmed/35287628
http://dx.doi.org/10.1186/s12885-021-09145-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919635/
https://www.ncbi.nlm.nih.gov/pubmed/35287628
http://dx.doi.org/10.1186/s12885-021-09145-0

Ejemplares similares